Evidence map›Paper›PMID 42415278›Full record

ArticleTraffic (Copenhagen, Denmark)2026

Syntaxin 12 Sustains Endosomal-Lysosomal Homeostasis and Survival in Glioblastoma Stem-Like Cells.

Clément Maghe, Agnieszka Barbach, Gwennan André-Grégoire, Clotilde C N Renaud, Margaux Le Guyon, Rosalie Moreau, Nicolas Bidère, Julie Gavard

Abstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Clément MagheCRCI2NA, Inserm, CNRS, Université de Nantes, Nantes, France.
Agnieszka BarbachCRCI2NA, Inserm, CNRS, Université de Nantes, Nantes, France.
Gwennan André-GrégoireCRCI2NA, Inserm, CNRS, Université de Nantes, Nantes, France.
Clotilde C N RenaudCRCI2NA, Inserm, CNRS, Université de Nantes, Nantes, France.
Margaux Le GuyonCRCI2NA, Inserm, CNRS, Université de Nantes, Nantes, France.
Rosalie MoreauCRCI2NA, Inserm, CNRS, Université de Nantes, Nantes, France.
Nicolas BidèreCRCI2NA, Inserm, CNRS, Université de Nantes, Nantes, France.
Julie GavardCRCI2NA, Inserm, CNRS, Université de Nantes, Nantes, France.ORCID https://orcid.org/0000-0002-7985-9007

Funding

Conseil Régional des Pays de la Loire, Trajectoire NationaleFondation ARC pour la Recherche sur le Cancer ARCPJA2021060003730Fondation ARC pour la Recherche sur le Cancer ARCPJA2025080010397Institut National Du Cancer 2023-044Institut National Du Cancer INCa PAIR-CEREB lNCa_16285Ligue Contre le Cancer Comités Ligue 35, 44, 49, 72, 85Ligue Contre le Cancer EL2022
6 · The paper itself

Abstract

Glioblastoma cells display a striking vulnerability to disruptions in late endosome-lysosome trafficking, a dependency that we exploited through a targeted siRNA screen in patient-derived cells with stem-like properties (GSCs). This screen identified Syntaxin 12 (STX12) as a critical determinant of GSC survival. Originally characterized as a recycling endosome t-SNARE, STX12 regulates tubular recycling and retrograde transport, yet its broader implications for lysosomal homeostasis remain poorly understood. Functional characterization revealed that STX12 is required to maintain lysosomal organization in GSCs, consistent with its known roles as an endosomal t-SNARE. Loss of STX12 altered dynamic processes that support GSC fitness, culminating in controlling life-and-death decisions. Because lysosomal function is deeply connected with the autophagic pathway, we next explored whether STX12 contributes to this adaptive program. STX12 silencing produced signatures consistent with impaired endo-lysosomal progression and disrupted mechanistic target of rapamycin (mTOR)/lysosome communication. This work further identifies a previously unrecognized role for STX12 in the adaptive trafficking network that supports glioblastoma cell survival, revealing a potential SNARE-centered vulnerability for therapeutic intervention.

Indexed as

EndosomesGlioblastomaLysosomesNeoplastic Stem CellsQa-SNARE ProteinsCell Line, TumorCell SurvivalHomeostasisHumansTOR Serine-Threonine KinasesQa-SNARE ProteinsTOR Serine-Threonine Kinasescell deathendo‐lysosomeglioblastomalysosomesmTOR signalingrecyclingtrafficking

Identifiers

PMID42415278
PMCPMC13342458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.